Caregiver support at different stages of Alzheimer's disease
Official title: Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
Run by Hospices Civils de Lyon · NCT07409506 · Data updated 2026-11-12
This project uses questionnaires to see how family caregivers help people aged 60 and older with Alzheimer's disease at different stages and what that care costs.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 312 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Villeurbanne) |
| Status | Recruiting |
| Started | September 9, 2025 |
| Main results expected | September 9, 2026 |
| Study ends | September 9, 2027 |
| Registry record updated | February 13, 2026 |
| Trial ID | NCT07409506 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are community-dwelling adults aged 60 or older with clinically probable Alzheimer's disease (MMSE ≤ 26) from the MEM-AURA cohort who are accompanied by an informal caregiver.
✕Probably not a fit
People living in nursing homes, those without an accompanying informal caregiver, or those under legal protection are not included and are unlikely to benefit from this study's findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study enrolls patients from the MEM-AURA cohort at Hôpital des Charpennes and their caregivers and uses the RUD (Resource Utilization in Dementia) questionnaire to record informal care activities and time. Eligible patients are community-dwelling adults with clinically probable Alzheimer's disease and an MMSE score ≤ 26 who attend with a caregiver, while those in institutions or under legal protection are excluded. Collected data will quantify caregiver time, tasks, and the economic value of informal care across disease stages to estimate the burden in a French setting. The results aim to inform healthcare planning and support services for families managing Alzheimer's disease at home.
Why it matters
Potential benefit: If successful, the findings could help shape policies and services that better support caregivers and help people with Alzheimer's remain at home longer.
How similar studies have gone: Previous observational studies using the RUD and similar instruments have repeatedly documented substantial informal care time and costs, so the methods are established though local estimates vary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients from Charpennes Hospital included in the MEM-AURA cohort * Patients aged 60 years and older at inclusion * Patients with dementia due to clinically probable Alzheimer's disease, regardless of stage * Patients with a Mini-Mental State Evaluation (MMSE) score ≤ 26 at inclusion * Patients accompanied by a caregiver at inclusion Exclusion Criteria: * \- Patients or caregivers who have expressed their opposition to the study * Patients living in institutions or nursing homes * Patients protected by law (under legal protection, guardianship, or conservatorship) Early termination Criteria : \- Patients or caregivers withdrawing their consent to participate during the study
Where it's running
-
Hôpital des Charpennes
Villeurbanne, France Recruiting
Study contacts
- Study coordinator: GERVAIS F M Frédéric GERVAIS
- Email: frederic.gervais02@chu-lyon.fr
- Phone: 0033 4 72 43 20 66
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acoustic Stimulation During Sleep for Alzheimer’s Disease
Researchers test whether playing gentle sounds during sleep can help people with Alzheimer’s disease see if their thinking improves compared with a sham sound.
-
FAME: A Italian test to recognize famous faces and name them
This project tests an Italian battery to see how well people with stroke or neurodegenerative diseases recognize famous faces and recall their names, familiarity, and related facts.
-
NMS-01 safety test in people with mild to moderate Alzheimer's disease
This pilot test checks whether the focused ultrasound device NMS-01 is safe and can briefly open the blood-brain barrier in adults with mild-to-moderate Alzheimer's disease.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Dignity Therapy for Older Adults in Long-Term Care
This study tests dignity therapy to help people 65 and older in long-term care see their lives as meaningful and preserve their sense of self.
-
Lecanemab-irmb in Real-World Use for Alzheimer’s Disease
This study tests the safety of lecanemab-irmb in people with Alzheimer’s disease by looking at real-world brain-image changes and related events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.